Data as of . Every figure is the buffer desk's own, on published data.
BAPR vs DOCT
Innovator U.S. Equity Buffer ETF - Apr and FT Vest U.S. Equity Deep Buffer ETF - October, side by side on the buffer desk.
Open the live comparison on ETFIQ| BAPR Innovator U.S. Equity Buffer ETF - Apr | DOCT FT Vest U.S. Equity Deep Buffer ETF - October | |
|---|---|---|
| Issuer | Innovator | First Trust |
| Reference index | SPY | SPY |
| Buffer | ||
| Outcome period | Mar 31, 2026 to Mar 31, 2027 | Oct 20, 2025 to Oct 16, 2026 |
| Days left | 208 | 42 |
| Starting cap | +18.5% | +11.7% |
| Can still gain | 6.0% | 0.9% |
| Fall before buffer | 10.6% | 14.3% |
| Protection left, index points | 9.0% of 9.0% | 25.0% of 25.0% |
| Index return this period | +18.4% | +15.9% |
| Fund return this period | +11.4% | +9.8% |
| State today | Open | At cap |
| Expense ratio | 0.79% | 0.85% |
BAPR in plain words
From its price on Sep 4, 2026, the fund can gain about 6.0% more before it reaches its cap. The fund's price can fall 10.6% from here before the buffer starts absorbing losses, by the issuer's figure. In index terms, SPY can fall 15.6% from today's level to the point where the buffer begins. Protection left, in index points: 9.0% of the 9.0% buffer still sits below today's SPY level. 208 days remained on Sep 4, 2026. On Mar 31, 2027 the period ends and a new cap is set.
DOCT in plain words
SPY had already risen past this fund's cap of +11.7% for the period on Sep 4, 2026, so in index terms there is no more upside to collect. The fund's own price can still drift up to about 0.9% as the period runs out. The fund's price can fall 14.3% from here before the buffer starts absorbing losses, by the issuer's figure. In index terms, SPY can fall 18.0% from today's level to the point where the buffer begins. Protection left, in index points: 25.0% of the 25.0% buffer still sits below today's SPY level. 42 days remained on Sep 4, 2026. On Oct 16, 2026 the period ends and a new cap is set.
Questions people ask
- Which has more room to gain, BAPR or DOCT?
- From their prices on Sep 4, 2026, BAPR can gain about 6.0% before its cap and DOCT about 0.9%, so BAPR has more room left this period.
- Which resets first, BAPR or DOCT?
- BAPR ends its outcome period on Mar 31, 2027 and DOCT on Oct 16, 2026. A new cap is set the day after each.
- Which is cheaper, BAPR or DOCT?
- BAPR charges 0.79% a year and DOCT charges 0.85%, so BAPR is cheaper. Fees come from each fund's prospectus.
Other comparisons
Cite this page. ETFIQ, BAPR against DOCT, data as of Sep 4, 2026. https://etfiq.com/compare/buffer/BAPR-DOCT.html Free to use with attribution; the underlying files are at Open data.
ETFIQ is an independent publisher of exchange-traded fund data. It is not a fund issuer, broker-dealer or investment adviser, and it makes no recommendations; every figure here is stated arithmetic on published data. Standards and sources